Abstract

ForI is a PLP-dependent enzyme from the biosynthetic pathway of the C-nucleoside antibiotic formycin. Cycloserine is thought to inhibit PLP-dependent enzymes by irreversibly forming a PMP-isoxazole. We now report that ForI forms novel PMP-diketopiperazine derivatives following incubation with both d and l cycloserine. This unexpected result suggests chemical diversity in the chemistry of cycloserine inhibition.

Highlights

  • Sisi Gao, ab Huanting Liu, b Valerie de Crecy-Lagard, c Wen Zhu, d Nigel G

  • ForI is a pyridoxal 50-phosphate (PLP)-dependent enzyme from the biosynthetic pathway of the C-nucleoside antibiotic formycin

  • We report that ForI forms novel pyridoxamine 50-phosphate (PMP)–diketopiperazine derivatives following incubation with both D and L cycloserine

Read more

Summary

Introduction

Sisi Gao, ab Huanting Liu, b Valerie de Crecy-Lagard, c Wen Zhu, d Nigel G. In each external aldimine complex, the atoms of the diketopiperazine adduct originating from PLP adopt the same positions as observed for the PMP structure.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.